Literature DB >> 20127351

The clinical course of idiopathic acute transverse myelitis in patients from Rio de Janeiro.

Marina Papais Alvarenga1, Luiz Claudio Santos Thuler, Silvio Peçanha Neto, Claudia Cristina Ferreira Vasconcelos, Solange Gomes Camargo, Marcos Papais Alvarenga, Regina Maria Papais-Alvarenga.   

Abstract

The aim of this study was to describe the demographic, clinical and laboratory features of idiopathic acute transverse myelitis (IATM). Patients with non-compressive ATM receiving care at Hospital da Lagoa, Rio de Janeiro (Brazil) between 2000 and 2008 were selected. Of the 70 cases of acute myelopathies, the idiopathic form was identified in 41 following exclusion of the cases associated with systemic lupus erythematosus (n = 1), Sjogren's syndrome (n = 1), herpes zoster (n = 1), cytomegalovirus in an HIV-positive patient (n = 1), Schistosoma mansoni (n = 1), actinic myelitis (n = 1), infectious myelitis of unknown etiology (n = 2) and those that, following the first attack of myelitis, converted to NMO (n = 19) or to clinically defined MS (n = 2). Of the 41 cases of IATM, the majority of patients were female (68.3%) and white (65.9%). Median age at first myelitis was 37.0 +/- 11.8 years. Over a median observation time of 36 months, 39.0% of patients remained monophasic, while recurrences occurred in 61.0% of cases. The number of ATM/patient ranged from one to seven. Among the recurrent cases the median time between the first and the second ATM was 12 months (range 1-150 months).The first myelitis was characterized mainly by partial myelitis with motor and sensorial dysfunction (63.4%). Complete and severe myelitis occurred more frequently among monophasic patients and partial myelitis with moderate dysfunction at onset in recurrent cases; however, over the long-term, dysfunction and disability were mild in both groups. Serial spine MRI confirmed spinal cord inflammation in 92.0% of cases and extensive spinal cord lesion was identified in 61.0%. Brain MRI was normal or not suggestive of MS in 94.4% of cases. CSF showed pleocytosis in 41.2%, increased IgG index in 24.0% and oligoclonal bands in 38.0% of 34 patients tested. Abnormal visual evoked potentials occurred in 11.5% of 26 patients. Positivity for anti-AQP4 was found in 23.5% of the 17 cases tested, suggesting limited forms of NMO. This study suggests some new aspects of the clinical course of IATM such as the high conversion rate to NMO, the predominance of women and a higher frequency of recurrent forms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127351     DOI: 10.1007/s00415-009-5450-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  NMO-IgG in the diagnosis of neuromyelitis optica.

Authors:  S Jarius; D Franciotta; R Bergamaschi; H Wright; E Littleton; J Palace; R Hohlfeld; A Vincent
Journal:  Neurology       Date:  2007-02-07       Impact factor: 9.910

Review 2.  Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis.

Authors:  Thomas F Scott; Salima L Kassab; Shalu Singh
Journal:  Mult Scler       Date:  2005-08       Impact factor: 6.312

3.  Acute transverse myelopathy in adults. A follow-up study.

Authors:  H L Lipton; R D Teasdall
Journal:  Arch Neurol       Date:  1973-04

4.  Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis.

Authors:  Brian G Weinshenker; Dean M Wingerchuk; Sandra Vukusic; Linda Linbo; Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

Review 5.  Diagnosis and management of acute myelopathies.

Authors:  Adam I Kaplin; Chitra Krishnan; Deepa M Deshpande; Carlos A Pardo; Douglas A Kerr
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

6.  Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002.

Authors:  Kortaro Tanaka; Yuki Kujuro; Shigeaki Suzuki; Norio Tanahashi; Junichi Hamada; Shigeru Nogawa; Norihiro Suzuki
Journal:  Intern Med       Date:  2005-06       Impact factor: 1.271

Review 7.  Proposed diagnostic criteria and nosology of acute transverse myelitis.

Authors: 
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

8.  Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events.

Authors:  D R Jeffery; R N Mandler; L E Davis
Journal:  Arch Neurol       Date:  1993-05

Review 9.  Transverse Myelitis: pathogenesis, diagnosis and treatment.

Authors:  Chitra Krishnan; Adam I Kaplin; Deepa M Deshpande; Carlos A Pardo; Douglas A Kerr
Journal:  Front Biosci       Date:  2004-05-01

10.  IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Authors:  Vanda A Lennon; Thomas J Kryzer; Sean J Pittock; A S Verkman; Shannon R Hinson
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

View more
  7 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

2.  Neuromyelitis optica: atipic clinic presentation.

Authors:  Emine Rabia Koç; Alevtina Ersoy; Atilla Ilhan
Journal:  Neurol Sci       Date:  2011-12-31       Impact factor: 3.307

3.  Acute transverse myelitis in demyelinating diseases among the Chinese.

Authors:  R Li; W Qiu; Z Lu; Y Dai; A Wu; Y Long; Y Wang; J Bao; X Hu
Journal:  J Neurol       Date:  2011-05-18       Impact factor: 4.849

4.  Anti-AQP(4) antibody in idiopathic acute transverse myelitis with recurrent clinical course: frequency of positivity and influence in prognosis.

Authors:  Marina Papais Alvarenga; Regina Maria Papais Alvarenga; Marcos Papais Alvarenga; Adriano Miranda Santos; Luiz Claudio Santos Thuler
Journal:  J Spinal Cord Med       Date:  2012-07       Impact factor: 1.985

5.  Assessment of Clinical Outcomes in Patients Presenting with Transverse Myelitis: A Tertiary Care Experience from a Developing Country.

Authors:  Aijaz Ali; Syeda Beenish Bareeqa; Amir Riaz; Syed Ijlal Ahmed; Muhammad Hassan Shaikh; Muhammad Ishaq Ghauri
Journal:  Cureus       Date:  2019-03-29

6.  Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.

Authors:  Alvaro Cobo Calvo; M Alba Mañé Martínez; Agustí Alentorn-Palau; Jordi Bruna Escuer; Lucía Romero Pinel; Sergio Martínez-Yélamos
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

Review 7.  Transverse myelitis.

Authors:  Shin C Beh; Benjamin M Greenberg; Teresa Frohman; Elliot M Frohman
Journal:  Neurol Clin       Date:  2013-02       Impact factor: 3.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.